Why the study?
Does admission blood glucose concentration or antecedent diabetes diagnosis better predict 30-day and 1-year mortality in patients with STEMI?
Population
4,702 consecutive patients with ST elevation acute myocardial infarction occurring from 1 April 1993 to 31…
Comparison
Admission blood glucose concentration and… vs Lower admission blood glucose and no antecedent…
Design
Cohort
Follow-up
30 days and 1 year
Authors
Loading...
Admission glucose may enhance short-term mortality stratification in STEMI beyond diabetes history; leaves open whether targeted intervention improves survival.
Does admission blood glucose concentration or antecedent diabetes diagnosis better predict 30-day and 1-year mortality in patients with STEMI?
Admission blood glucose concentration is a stronger predictor of 30-day and 1-year mortality after STEMI than a prior diagnosis of diabetes, with even moderate glucose elevations impacting survival.
Squire et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: